Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Hydroxychloroquine can help treat certain types of hair loss.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Tph cells are linked to the severity of systemic lupus erythematosus.

The new method combining dermoscopy and Reflectance Confocal Microscopy is more effective for evaluating vitiligo.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Hydroxychloroquine may help COVID-19 patients with lupus.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.